Last reviewed · How we verify
NCT06611254
Quantification of Brain and Kidney Perfusion Before, During, and After Hypothermia Treatment in Neonates With Perinatal Asphyxia Using Contrast-enhanced Ultrasound
trial testing Contrast enhanced ultrasound imaging (CEUS) and post processing with ULM in Perinatal Asphyxia in 20 participants. Currently enrolling.
1 July 2027
Quick facts
| Lead sponsor | University of Erlangen-Nürnberg Medical School |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 24 June 2024 |
| Primary completion | 1 July 2027 |
| Estimated completion | 1 December 2027 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Contrast enhanced ultrasound imaging (CEUS) and post processing with ULM
Conditions studied
- Perinatal Asphyxia — all drugs for Perinatal Asphyxia →
- Hypothermia Treatment — all drugs for Hypothermia Treatment →
- Gestational Age Min. 36SSW — all drugs for Gestational Age Min. 36SSW →
Sponsor
University of Erlangen-Nürnberg Medical School
Who can join
Eligibility, any sex, with Perinatal Asphyxia or Hypothermia Treatment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this clinical study vascular dynamics in the neonatal brain and kidney will be monitored by CUES and ULM before, during and after hypothermia treatment in neonates with asphyxia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06611254
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Contrast enhanced ultrasound imaging (CEUS) and post processing with ULM
Trials testing the same drug.
- NCT06921733 — Ultrasound Localization Microscopy in Patient With Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) · recruiting
Other recruiting trials for Perinatal Asphyxia
Currently open trials in the same condition.
- NCT06747260 — Feasibility and Safety of Intranasally Administered Breast Milk in HIE · EARLY_PHASE1 · recruiting
Other University of Erlangen-Nürnberg Medical School trials
Trials by the same sponsor.
- NCT06969820 — Establishment and Evaluation of Standardized Clinical, Biological and Imaging Parameters to Assess the Response of LDRT · not yet recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07352540 — Single vs Triple Hyaluronic Acid in Knee Osteoarthritis · Phase 2, PHASE3 · not yet recruiting
- NCT07313878 — Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Micros · NA · recruiting
- NCT07121985 — Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré S · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06611254 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Erlangen-Nürnberg Medical School
- Last refreshed: 24 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06611254.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing